Natural killer T cells in liver injury, inflammation and cancer

References

• Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013;13(2):101-17
   PubMed Web of Science ®Google Scholar
• Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2(8):557-68
   PubMed Web of Science ®Google Scholar
• Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007;25:297-336
   PubMed Web of Science ®Google Scholar
• Van Kaer L, Parekh VV, Wu L. Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res 2011;343(1):43-55
   PubMed Web of Science ®Google Scholar
• Wu L, Van Kaer L. Natural killer T cells in health and disease. Front Biosci (Schol Ed) 2011;3:236-51
   PubMedGoogle Scholar
• Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004;22:817-90
   PubMed Web of Science ®Google Scholar
• Rossjohn J, Pellicci DG, Patel O, et al. Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 2012;12(12):845-57
   PubMed Web of Science ®Google Scholar
• Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011;11(2):131-42
   PubMed Web of Science ®Google Scholar
• Wilson MT, Johansson C, Olivares-Villagomez D, et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A 2003;100(19):10913-18
   PubMed Web of Science ®Google Scholar
• Leite-de-Moraes MC, Herbelin A, Gouarin C, et al. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J Immunol 2000;165(8):4367-71
   PubMed Web of Science ®Google Scholar
• Parekh VV, Singh AK, Wilson MT, et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids. J Immunol 2004;173(6):3693-706
   PubMed Web of Science ®Google Scholar
• Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009;86(3):513-28
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007;7(7):505-18
   PubMed Web of Science ®Google Scholar
• Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997;278(5343):1626-9
   PubMed Web of Science ®Google Scholar
• Velazquez P, Cameron TO, Kinjo Y, et al. Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J Immunol 2008;180(4):2024-8
   PubMed Web of Science ®Google Scholar
• Winau F, Hegasy G, Weiskirchen R, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007;26(1):117-29
   PubMed Web of Science ®Google Scholar
• Schmieg J, Yang G, Franck RW, et al. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A 2005;102(4):1127-32
   PubMed Web of Science ®Google Scholar
• Geissmann F, Cameron TO, Sidobre S, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005;3(4):e113
   PubMed Web of Science ®Google Scholar
• De Santo C, Salio M, Masri SH, et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 2008;118(12):4036-48
   PubMed Web of Science ®Google Scholar
• Zeissig S, Murata K, Sweet L, et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 2012;18(7):1060-8
   PubMed Web of Science ®Google Scholar
• Emoto M, Mittrucker HW, Schmits R, et al. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J Immunol 1999;162(9):5094-8
   PubMed Web of Science ®Google Scholar
• Thomas SY, Scanlon ST, Griewank KG, et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 2011;208(6):1179-88
   PubMed Web of Science ®Google Scholar
• Li Z, Oben JA, Yang S, et al. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 2004;40(2):434-41
   PubMed Web of Science ®Google Scholar
• Syn WK, Witek RP, Curbishley SM, et al. Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol 2009;39(7):1879-92
   PubMed Web of Science ®Google Scholar
• Syn WK, Agboola KM, Swiderska M, et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 2012;61(9):1323-9
   PubMed Web of Science ®Google Scholar
• Godfrey DI, MacDonald HR, Kronenberg M, et al. NKT cells: what’s in a name? Nat Rev Immunol 2004;4(3):231-7
   PubMed Web of Science ®Google Scholar
• Billerbeck E, Kang YH, Walker L, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 2010;107(7):3006-11
   PubMed Web of Science ®Google Scholar
• Karadimitris A, Gadola S, Altamirano M, et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A 2001;98(6):3294-8
   PubMed Web of Science ®Google Scholar
• Tilloy F, Treiner E, Park SH, et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med 1999;189(12):1907-21
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Martin E, Peguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010;1(8):701-8
   Google Scholar
• Treiner E, Lantz O. CD1d- and MR1-restricted invariant T cells: of mice and men. Cur Opin Immunol 2006;18(5):519-26
   PubMed Web of Science ®Google Scholar
• Tang XZ, Jo J, Tan AT, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol 2013;190(7):3142-52
   PubMed Web of Science ®Google Scholar
• Ussher JE, Bilton M, Attwod E, et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol 2014;44(1):195-203
   PubMed Web of Science ®Google Scholar
• Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmun Rev 2011;10(12):793-800
   PubMed Web of Science ®Google Scholar
• Duwaerts CC, Gregory SH. Targeting the diverse immunological functions expressed by hepatic NKT cells. Expert Opin Ther Targets 2011;15(8):973-88
   PubMed Web of Science ®Google Scholar
• Martin-Murphy BV, Kominsky DJ, Orlicky DJ, et al. Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury. Hepatology 2013;57(4):1575-84
   PubMed Web of Science ®Google Scholar
• Wang H, Feng D, Park O, et al. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-gamma. Hepatology 2013;58(4):1474-85
   PubMed Web of Science ®Google Scholar
• Yin S, Wang H, Bertola A, et al. Activation of invariant natural killer T cells impedes liver regeneration by way of both IFN-gamma- and IL-4-dependent mechanisms. Hepatology 2014;60(4):1356-66
   PubMed Web of Science ®Google Scholar
• Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev 2010;90(3):1165-94
   PubMed Web of Science ®Google Scholar
• Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology 2008;47(2):729-36
   PubMed Web of Science ®Google Scholar
• Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol 2013;14(10):996-1006
   PubMed Web of Science ®Google Scholar
• Liaskou E, Wilson DV, Oo YH. Innate immune cells in liver inflammation. Mediators Inflamm 2012;2012:949157
   PubMed Web of Science ®Google Scholar
• Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 2005;175(3):1540-50
   PubMed Web of Science ®Google Scholar
• Takeda K, Hayakawa Y, Van Kaer L, et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 2000;97(10):5498-503
   PubMed Web of Science ®Google Scholar
• Biburger M, Tiegs G. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 2008;84(1):264-79
   PubMed Web of Science ®Google Scholar
• Jaruga B, Hong F, Sun R, et al. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 2003;171(6):3233-44
   PubMed Web of Science ®Google Scholar
• Louis H, Le Moine A, Flamand V, et al. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 2002;122(7):2001-10
   PubMed Web of Science ®Google Scholar
• Wondimu Z, Santodomingo-Garzon T, Le T, Swain MG. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. Am J Pathol 2010;177(5):2334-46
   PubMed Web of Science ®Google Scholar
• Sun R, Tian Z, Kulkarni S, Gao B. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J Immunol 2004;172(9):5648-55
   PubMed Web of Science ®Google Scholar
• Vilarinho S, Ogasawara K, Nishimura S, et al. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A 2007;104(46):18187-92
   PubMed Web of Science ®Google Scholar
• Hosoya S, Ikejima K, Takeda K, et al. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol 2013;304(3):G293-9
   Web of Science ®Google Scholar
• Kawamura T, Takeda K, Kaneda H, et al. NKG2A inhibits invariant NKT cell activation in hepatic injury. J Immunol 2009;182(1):250-8
   PubMed Web of Science ®Google Scholar
• Mathews S, Feng D, Maricic I, et al. Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol 2015
   PubMed Web of Science ®Google Scholar
• Maricic I, Sheng H, Marrero I, et al. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 2015;61(4):1357-69
   PubMed Web of Science ®Google Scholar
• Cui K, Yan G, Xu C, et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1beta in mice. J Hepatol 2015;62(6):1311-18
   PubMed Web of Science ®Google Scholar
• Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 2014;14(3):181-94
   PubMed Web of Science ®Google Scholar
• Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64(5):830-41
   PubMed Web of Science ®Google Scholar
• Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Comprehensive Physiology 2013;3(4):1473-92
   PubMed Web of Science ®Google Scholar
• Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013;5(167):167sr161
   Web of Science ®Google Scholar
• Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7(8):425-36
   PubMed Web of Science ®Google Scholar
• Mitra A, Satelli A, Yan J, et al. IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology 2014;60(6):2027-39
   PubMed Web of Science ®Google Scholar
• Miyagi T, Takehara T, Tatsumi T, et al. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver. Int J Cancer 2003;106(1):81-9
   PubMed Web of Science ®Google Scholar
• Jin Z, Sun R, Wei H, et al. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 2011;53(1):219-29
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Ikejima K, Yamagata H, et al. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J Hepatol 2011;54(6):1195-204
   PubMed Web of Science ®Google Scholar
• Park O, Jeong WI, Wang L, et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009;49(5):1683-94
   PubMed Web of Science ®Google Scholar
• Gao B, Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 2013;1832(7):1061-9
   PubMed Web of Science ®Google Scholar
• Radaeva S, Sun R, Jaruga B, et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006;130(2):435-52
   PubMed Web of Science ®Google Scholar
• Melhem A, Muhanna N, Bishara A, et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 2006;45(1):60-71
   PubMed Web of Science ®Google Scholar
• Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008;134(4):657-67
   PubMed Web of Science ®Google Scholar
• Muhanna N, Abu Tair L, Doron S, et al. Amelioration of hepatic fibrosis by NK cell activation. Gut 2011;60(1):90-8
   PubMed Web of Science ®Google Scholar
• Muhanna N, Doron S, Wald O, et al. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. Hepatology 2008;48(3):963-77
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Suh YG, et al. Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 2011;53(4):1342-51
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008;134(1):248-58
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 2006;44(6):1441-51
   PubMed Web of Science ®Google Scholar
• Wu SJ, Yang YH, Tsuneyama K, et al. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011;53(3):915-25
   PubMed Web of Science ®Google Scholar
• Wehr A, Baeck C, Heymann F, et al. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. J Immunol 2013;190(10):5226-36
   PubMed Web of Science ®Google Scholar
• Syn WK, Oo YH, Pereira TA, et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 2010;51(6):1998-2007
   PubMed Web of Science ®Google Scholar
• de Lalla C, Galli G, Aldrighetti L, et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 2004;173(2):1417-25
   PubMed Web of Science ®Google Scholar
• Kremer M, Thomas E, Milton RJ, et al. Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology 2010;51(1):130-41
   PubMed Web of Science ®Google Scholar
• Guebre-Xabier M, Yang S, Lin HZ, et al. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 2000;31(3):633-40
   PubMed Web of Science ®Google Scholar
• Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2009;21(6):673-80
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Advances in liver regeneration. Expert Rev Gastroenterol Hepatol 2014;8(8):897-907
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010;176(1):2-13
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol 2013;3(1):485-513
   PubMed Web of Science ®Google Scholar
• Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol 2012;57(3):692-4
   PubMed Web of Science ®Google Scholar
• Fausto N. Involvement of the innate immune system in liver regeneration and injury. J Hepatol 2006;45(3):347-9
   PubMed Web of Science ®Google Scholar
• Van Sweringen HL, Sakai N, Tevar AD, et al. CXC chemokine signaling in the liver: impact on repair and regeneration. Hepatology 2011;54(4):1445-53
   PubMed Web of Science ®Google Scholar
• Tumanov AV, Koroleva EP, Christiansen PA, et al. T cell-derived lymphotoxin regulates liver regeneration. Gastroenterology 2009;136(2):694-704
   PubMed Web of Science ®Google Scholar
• Rao R, Graffeo CS, Gulati R, et al. Interleukin 17-producing gammadeltaT cells promote hepatic regeneration in mice. Gastroenterology 2014;147(2):473-84
   PubMed Web of Science ®Google Scholar
• Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004;127(5):1525-39
   PubMed Web of Science ®Google Scholar
• Minagawa M, Oya H, Yamamoto S, et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 2000;31(4):907-15
   PubMed Web of Science ®Google Scholar
• Dong Z, Zhang J, Sun R, et al. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007;45(6):1400-12
   PubMed Web of Science ®Google Scholar
• Nakashima H, Inui T, Habu Y, et al. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 2006;131(5):1573-83
   PubMed Web of Science ®Google Scholar
• Sun R, Park O, Horiguchi N, et al. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology 2006;44(4):955-66
   PubMed Web of Science ®Google Scholar
• DeAngelis RA, Markiewski MM, Kourtzelis I, et al. A complement-IL-4 regulatory circuit controls liver regeneration. J Immunol 2012;188(2):641-8
   PubMed Web of Science ®Google Scholar
• Goh YP, Henderson NC, Heredia JE, et al. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci USA 2013;110(24):9914-19
   PubMed Web of Science ®Google Scholar
• Vivier E, Ugolini S, Blaise D, et al. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012;12(4):239-52
   PubMed Web of Science ®Google Scholar
• Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia 2003;17(6):1068-77
   PubMed Web of Science ®Google Scholar
• Song L, Asgharzadeh S, Salo J, et al. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest 2009;119(6):1524-36
   PubMed Web of Science ®Google Scholar
• Terabe M, Swann J, Ambrosino E, et al. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 2005;202(12):1627-33
   PubMed Web of Science ®Google Scholar
• Tahir SM, Cheng O, Shaulov A, et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol 2001;167(7):4046-50
   PubMed Web of Science ®Google Scholar
• Tachibana T, Onodera H, Tsuruyama T, et al. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res 2005;11(20):7322-7
   PubMed Web of Science ®Google Scholar
• Schneiders FL, de Bruin RC, van den Eertwegh AJ, et al. Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up. J Clin Oncol 2012;30(5):567-70
   PubMed Web of Science ®Google Scholar
• Tatsumi T, Takehara T, Yamaguchi S, et al. Intrahepatic delivery of alpha-galactosylceramide-pulsed dendritic cells suppresses liver tumor. Hepatology 2007;45(1):22-30
   PubMed Web of Science ®Google Scholar
• Anson M, Crain-Denoyelle AM, Baud V, et al. Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 2012;122(2):586-99
   PubMed Web of Science ®Google Scholar
• Wolf MJ, Adili A, Piotrowitz K, et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 2014;26(4):549-64
   PubMed Web of Science ®Google Scholar
• Bricard G, Cesson V, Devevre E, et al. Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J Immunol 2009;182(8):5140-51
   PubMed Web of Science ®Google Scholar
• Crowe NY, Coquet JM, Berzins SP, et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 2005;202(9):1279-88
   PubMed Web of Science ®Google Scholar
• Schneiders FL, Scheper RJ, von Blomberg BM, et al. Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clin Immunol 2011;140(2):130-41
   PubMed Web of Science ®Google Scholar
• Veldt BJ, van der Vliet HJ, von Blomberg BM, et al. Randomized placebo controlled Phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C. J Heptol 2007;47(3):356-65
   PubMed Web of Science ®Google Scholar